When is J Pharma Co Ltd's IPO?

J Pharma Co Ltd's IPO is currently expected around Mar 25, 2026 on JPX Growth. IPO dates can move until the company files and prices the offering, so we keep this page updated as new details are confirmed.

What is J Pharma Co Ltd's expected IPO price?

J Pharma Co Ltd's expected IPO price is $5.46 per share.

Is J Pharma Co Ltd publicly traded?

Not yet — J Pharma Co Ltd is still a private company, so its shares aren't available on public exchanges. IPO Tracker monitors pre-IPO markets, IPO filings and the IPO calendar, so J Pharma Co Ltd's pre-IPO price and IPO date will appear here as soon as they're available.

All companies

J Pharma Co Ltd

520A

IPO Upcoming

IPO UpcomingJapan(JPX Growth)0 markets

Official IPO

Priced· JPX Growth· Listing market: Japan

IPO date

Mar 25, 2026

Final IPO price

$5.46

Shares offered

To be announced

IPO raise

To be announced

Sources: jpx

No live market is quoted for J Pharma Co Ltd yet. Get in line for IPO-day access through a broker in the meantime.

eToro

Invest in stocks once they list with eToro

Trade stocks, ETFs and crypto from one simple account.

Start with eToro

About J Pharma Co Ltd

J Pharma Co Ltd is a healthcare and life-sciences company with a business profile centered on medical products, therapies, diagnostics, or health-related services.

What the company does

Develops healthcare products, therapies, devices, or services where clinical evidence and regulatory execution are central to the business.
Operates in a market shaped by product differentiation, development timelines, reimbursement or customer adoption, and disciplined capital allocation.
Relies on technical, clinical, commercial, and operational teams to move products from development toward broader use.

Business profile

J Pharma Co Ltd belongs to the healthcare and life-sciences market, where product evidence, regulatory pathways, customer adoption, and funding discipline shape long-term outcomes.

Latest J Pharma Co Ltd IPO news

Recent sourced articles classified for IPO relevance, with platform-access noise filtered out where possible.

J-Pharma Announces jRCT Registration of an Investigator-Initiated Trial of Nanvuranlat in Combination with Immune Checkpoint Inhibitors for Biliary Tract Cancer

J-Pharma Co., Ltd.May 18, 2026IPO filing

J-Pharma said on May 18, 2026 that an investigator-initiated clinical trial, JON-2404-B, was registered on Japan Registry of Clinical Trials in preparation for launch. The study will test nanvuranlat in combination with immune checkpoint inhibitors as first-line therapy for biliary tract cancer.

J Pharma Co Ltd IPO — frequently asked questions

When is J Pharma Co Ltd's IPO?: J Pharma Co Ltd's IPO is currently expected around Mar 25, 2026 on JPX Growth. IPO dates can move until the company files and prices the offering, so we keep this page updated as new details are confirmed.
What is J Pharma Co Ltd's expected IPO price?: J Pharma Co Ltd's expected IPO price is $5.46 per share.
Is J Pharma Co Ltd publicly traded?: Not yet — J Pharma Co Ltd is still a private company, so its shares aren't available on public exchanges. IPO Tracker monitors pre-IPO markets, IPO filings and the IPO calendar, so J Pharma Co Ltd's pre-IPO price and IPO date will appear here as soon as they're available.